R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

Clinical trial NCT06057454 · COMPLETED

Trial details

NCT number: NCT06057454
Sponsor: Rise Therapeutics LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes Type 1 Diabetes (Juvenile Onset)Diabetes Mellitus, Type 1

Start date: 2023-12-05
Primary completion: 2025-11-05
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.